Laurus Labs Ltd

NSE: LAURUSLABS · BSE: 540222 · Pharmaceuticals & Biotechnology · 38 announcements

Share price: ₹2,050.00
Market cap: ₹1,10,764 Cr
Revenue (annual): ₹6,813 Cr
Net profit (annual): ₹888.8 Cr
P/E (TTM): 101.3×Sector 47.4×
Promoter holding: 27.47%-0.02% QoQ
FII holding: 28.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Merger & Restructuring 5 Other Announcement 4 Financial Results 4 Board Meeting Outcome 4 Management Change 3 Results Update 2 Employee Stock Options 2 Dividend 2 Annual General Meeting 2 Results Correction 1 Credit Rating 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

30 Apr 2026 22:07 IST NSE

Dividend

Laurus Labs Dividend

Laurus Labs Limited declared an interim dividend of ₹1.2 per equity share for FY 2025-26. The board fixed May 8, 2026, as the record date, with payment scheduled to be completed by May 20, 2026.

Read the filing ↗

30 Apr 2026 15:29 IST NSE

Dividend

Laurus Labs Dividend

Laurus Labs Limited has declared a 2nd Interim Dividend of Rs.1.20 (60%) per equity share for FY 2025-26. The company has fixed May 08, 2026, as the record date. The dividend payment will be made on or after May 20, 2026.

Read the filing ↗